PICO Portalanswers from OpenAlex
Bimekizumab versus Secukinumab in Plaque Psoriasis
PaperCitations, authors & open-access status
Bimekizumab versus Secukinumab in Plaque Psoriasis is a paper indexed in PICO Portal from OpenAlex.
How many citations does Bimekizumab versus Secukinumab in Plaque Psoriasis have?
PICO Portalcitation count
Bimekizumab versus Secukinumab in Plaque Psoriasis has 411 citations in the OpenAlex counts PICO Portal stores.
When was Bimekizumab versus Secukinumab in Plaque Psoriasis published?
PICO Portalyear
Bimekizumab versus Secukinumab in Plaque Psoriasis has 2021 year in the PICO Portal index.
What is the open-access status of Bimekizumab versus Secukinumab in Plaque Psoriasis?
PICO Portaloa status
Bimekizumab versus Secukinumab in Plaque Psoriasis has closed oa status in the PICO Portal index.
What is the DOI of Bimekizumab versus Secukinumab in Plaque Psoriasis?
PICO Portaldoi
The DOI for Bimekizumab versus Secukinumab in Plaque Psoriasis is on the source record.
What is the PMID of Bimekizumab versus Secukinumab in Plaque Psoriasis?
PICO Portalpmid
The PMID for Bimekizumab versus Secukinumab in Plaque Psoriasis is on the source record.
What is the OpenAlex record for Bimekizumab versus Secukinumab in Plaque Psoriasis?
PICO Portalopenalex
The OpenAlex for Bimekizumab versus Secukinumab in Plaque Psoriasis is on the source record.